Clinical trial Recruiting at 3 sites Observational Ages 40 and up

Hip osteoarthritis: follow-up of patients treated with intra-articular hyaluronic acid

Official title: Clinical Follow-up Study of Patients With Hip Osteoarthritis Treated With Intra-Articular Hyaluronic Acid

Run by Meiji Pharma Spain S.A. · NCT07883395 · Data updated 2026-11-12

This study follows adults over 40 with symptomatic hip OA who are already receiving hyaluronic acid injections to see how they fare in routine clinical practice in Spain.

More Osteoarthritis (OA) of the Hip trials

Quick facts

Study typeObservational
Ages40 Years and up
SexAll
Enrollment40 (estimated)
SponsorMeiji Pharma Spain S.A.
Industry-sponsored
Locations4 sites (Madrid and 3 other locations)
StatusRecruiting
StartedJanuary 29, 2026
Main results expectedApril 2027
Study endsApril 2027
Registry record updatedOctober 20, 2026
Trial IDNCT07883395 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 40 with at least 1 year of symptomatic hip OA, radiographic KOA grade II-III, and currently receiving intra-articular hyaluronic acid.

Probably not a fit

Patients without ongoing hyaluronic acid treatment or with factors outside the eligibility criteria may not experience documented benefits from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects real-world data from adults aged 40 and older with hip osteoarthritis treated with intra-articular hyaluronic acid in several Spanish hospitals. Participants must have had symptoms for at least a year, radiographic KOA grades II–III, and a WOMAC score above 15, among other criteria. The investigation aims to document outcomes in standard clinical use rather than test an intervention. Data are drawn from patients treated within Traumatology and Rehabilitation departments of participating centers. The study is sponsored by Meiji Pharma Spain S.A. with academic and hospital collaborators.

Why it matters

Potential benefit: If successful, the study could clarify how intra-articular hyaluronic acid performs in real-world hip OA care and inform future treatment decisions.

How similar studies have gone: Observational real-world studies of hyaluronic acid for hip OA have yielded varied results but contribute valuable context for routine use.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: \>40 years at the time of study inclusion
* Preserved gait capability, with or without assistive devices
* Symptomatic hip arthropathy with a disease evolution of at least 1 year.
* Radiographic Kellgren-Lawrence grade II-III documented within the 12 months prior to study entry
* Total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score \>15
* Patient currently receiving intra-articular hyaluronic acid treatment within 3 months prior to study inclusion

Exclusion Criteria:

* Refusal to provide written informed consent
* Females who are pregnant, breastfeeding, or not using effective contraception
* Body Mass Index (BMI) ≥ 30 kg/m²
* Presence of other chronic or autoimmune diseases that could interfere with clinical evaluation
* History of hypersensitivity or allergy to hyaluronic acid or its derivatives
* Prior administration of intra-articular platelet-rich plasma (PRP) or intra-articular corticosteroids within 3 months, or intra-articular hyaluronic acid within 6 months prior to study entry

Where it's running

  • Hospital Universitario de La Princesa
    Madrid, Spain
    Recruiting
  • Hospital Universitario de La Princesa
    Madrid, Spain
    Recruiting
  • QuironSalud. Hospital Juan Bravo
    Madrid, Spain
    Recruiting
  • Hospital Provincial Nuestra Señora de Gracia
    Zaragoza, Spain
    Not yet recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.